(Q42596945)

3 November 2017

title

Direct effect on validity of response run-in selection in clinical trials (English)

1 reference

3 November 2017

1 reference

https://api.crossref.org/works/10.1016/S0197-2456(02)00316-1

23 December 2023

author name string

Azadeh Rezvani

series ordinal

2

1 reference

3 November 2017

Vance W. Berger

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12689737

23 December 2023

Vanessa A. Makarewicz

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12689737

23 December 2023

language of work or name

English

0 references

publication date

1 April 2003

1 reference

full work available at URL

3 November 2017

https://api.elsevier.com/content/article/PII:S0197245602003161?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0197-2456(02)00316-1

https://api.elsevier.com/content/article/PII:S0197245602003161?httpAccept=text/plain

23 December 2023

1 reference

DOI

https://api.crossref.org/works/10.1016/S0197-2456(02)00316-1

Contemporary Clinical Trials

23 December 2023

published in

1 reference

3 November 2017

volume

24

1 reference

3 November 2017

issue

2

1 reference

3 November 2017

page(s)

156-166

1 reference

Ventricular Arrhythmias: Risk Stratification and Approach to Therapy After the Cardiac Arrhythmia Suppression Trial (CAST)

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

The qualification period

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

The introductory placebo washout: a retrospective evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Randomized discontinuation trials: Utility and efficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Perusing the literature: comparison of MEDLINE searching with a perinatal trials database

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Identifying relevant studies for systematic reviews

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

The run-in period in clinical trials. The effect of misclassification on efficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Value of a run-in period in a drug trial during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

A comprehensive algorithm for determining whether a run-in strategy will be a cost-effective design modification in a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Run-in periods in randomized trials: implications for the application of results in clinical practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

An empirical evaluation of the placebo run-in

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Threats to the validity of clinical trials employing enrichment strategies for sample selection

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Pros and cons of permutation tests in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

End-point interpretation in clinical trials: the case for discipline

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Treatment allocation methods in clinical trials: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Validity versus generalizability in clinical trial design and conduct.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Detecting selection bias in randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Rationale, objectives, and interpretation of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Selection bias and treatment heterogeneity in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Simultaneous-equation estimation in a clinical trial of the effect of smoking on birth weight

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Is there a need to control the placebo in placebo controlled trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Intention-to-treat analysis: implications for quantitative and qualitative research

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Methodologic issues in maintenance therapy clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Limitations of the Application of Fourfold Table Analysis to Hospital Data

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900316-1

7 January 2021

Identifiers

DOI

1 reference

3 November 2017

1 reference